Dojin Clinic: Advancing the Legacy of Six-Cell Combination Immunotherapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
In the journey of cancer treatment, the fusion of pioneering research and dedicated medical leadership is paramount. Dojin Clinic, located in Fukuoka, stands as a premier institution for advanced immune cell therapy in Japan.
The Foundation: Dr. Tsuneo Kuramochi (deceased)’s Breakthrough
The world-renowned "Six-Cell Combination Immunotherapy" was originally developed by the late Dr. Tsuneo Kuramochi, a pioneer in oncology immunology. His life’s work focused on reactivating the patient's innate healing power. This unique technology, which simultaneously activates six different types of immune cells, holds dual patents in Japan and Korea.
Current Leadership: Dr. Toshihide Aso
Today, the clinic is directed by Dr. Toshihide Aso, a distinguished graduate of the Kyushu University School of Medicine. With an extensive background in cardiovascular surgery and international medical relief, Dr. Aso brings a global perspective and rigorous scientific standards to the clinic.
Under Dr. Aso’s guidance, Dojin Clinic continues to refine and implement Dr. Kuramochi’s patented protocols, ensuring that every cell preparation meets the highest standards of purity and antitumor activity within their certified Cell Processing Center (CPC).
Why Choose Dojin Clinic?
- Comprehensive Immune Defense: Simultaneously activates γδT cells, NK cells, NKT cells, CTLs, Dendritic Cells (DC), and Helper T cells to create a powerful immune army.
- Scale of Activation: The clinic can expand a patient’s immune cells to a staggering 20 to 50 billion cells per cycle, providing a robust response against metastatic disease.
- Patient-Centered Care: Designed for international patients, the clinic offers a supportive and compassionate environment, allowing for outpatient treatment with minimal side effects.
[Medical Supporter Compliance Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.